欢迎来到天天文库
浏览记录
ID:46261093
大小:70.54 KB
页数:42页
时间:2019-11-22
《益气温阳法治疗变应性鼻炎的临床分析》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、中文摘要目的:本课题为观察摄涕止軌汤治疗肺肾气虚型变应性鼻炎的临床疗效,对英有效性进行评价,初步探讨其作用机制,了解摄涕止軌汤加味在肺肾气虚型AR治疗方面的优势,为中医药治疗AR的研究积累一定依据。方法:本课题大体分为三个阶段进行,第一阶段为制定研究方案,依据日前公认的标准制定诊断标准、观察指标、积分标准、疗效评定标准等;依照现行统计学文献确定研究病例数。第二阶段为临床研究阶段,将所收集临床病例随机分成两组进行治疗,治疗组35例,应用摄涕止軌汤加味口服,对照组35例,应用鼻舒适片口服,疗程均为28天。治疗过程中观察并记录两组患者症状、体征变化及不良反应。第三阶段将收
2、集资料进行整理、统计学处理及治疗结果分析。结果:两组患者总体疗效统计学处理结果显示,P3、ciencytypeofLungandKidneyARbyShetiZhiqiudecoction,makeanevaluationoftheeffectiveness,studyitsmechanismpreliminary,haveaknowledgeoftheadvantageintreatingQi-DeficiencytypeofLungandKidneyARbyShetiZhiqiudecoction,andaccumulateseveraldatasfortreatingAllergicRhinitiswithtraditionalChinesemed4、icine.Methods:Thestudywascarriedoutinthreestages.Inthefirststage,astudyschemewasmade.Accordingtotheneweststandard,thediagnosisstandardobservationtarget,markstandard,appraisalstandardweremade.Thenumberofpatientsisfixedaccordingtotherecentfeachingmaterialofstatistics.Thesecondstagewasacl5、inicstudyone.Thepatientsweredividedintotwogroupsaccordingtoarandomnumbertable:thetestgroupof35caseswastreatedwithShetiZhiqiudecoctionandthecontrolgroupof35caseswithBishushitablets,bothgroupsweregiventreatmentfor28days.Duringthetherapeuticperiod,thedoctorobservedandrecordedthechangesoft6、hepatients?symptoms,signsandadversereactions.Thecollecteddataweremarshaled,thensettleddownstatisticallyandanalyzedinthethirdstage.Results:Theresultshowsthatthetotalefficacyofthetestgroupcomparingwiththatofthecontrolgrouptostatisticalanalze,P<0.05.Itimpliedthattherearedifferencesintheto7、talefficacybeteenShetiZhiqiudecoctionandBishushitablets・Conclusion:Qi-DeficiencyofLungandKidneyisonecaseofAR.ShetiZhiqiudecoctionhasaroleofsupplementQitowarmYang,andabettertreatefficacyinQi-DeficiencytypeofLungandKidney.ltcanbetterconrrolpatients'symptomsandsigns.ltisworthtopromotean
3、ciencytypeofLungandKidneyARbyShetiZhiqiudecoction,makeanevaluationoftheeffectiveness,studyitsmechanismpreliminary,haveaknowledgeoftheadvantageintreatingQi-DeficiencytypeofLungandKidneyARbyShetiZhiqiudecoction,andaccumulateseveraldatasfortreatingAllergicRhinitiswithtraditionalChinesemed
4、icine.Methods:Thestudywascarriedoutinthreestages.Inthefirststage,astudyschemewasmade.Accordingtotheneweststandard,thediagnosisstandardobservationtarget,markstandard,appraisalstandardweremade.Thenumberofpatientsisfixedaccordingtotherecentfeachingmaterialofstatistics.Thesecondstagewasacl
5、inicstudyone.Thepatientsweredividedintotwogroupsaccordingtoarandomnumbertable:thetestgroupof35caseswastreatedwithShetiZhiqiudecoctionandthecontrolgroupof35caseswithBishushitablets,bothgroupsweregiventreatmentfor28days.Duringthetherapeuticperiod,thedoctorobservedandrecordedthechangesoft
6、hepatients?symptoms,signsandadversereactions.Thecollecteddataweremarshaled,thensettleddownstatisticallyandanalyzedinthethirdstage.Results:Theresultshowsthatthetotalefficacyofthetestgroupcomparingwiththatofthecontrolgrouptostatisticalanalze,P<0.05.Itimpliedthattherearedifferencesintheto
7、talefficacybeteenShetiZhiqiudecoctionandBishushitablets・Conclusion:Qi-DeficiencyofLungandKidneyisonecaseofAR.ShetiZhiqiudecoctionhasaroleofsupplementQitowarmYang,andabettertreatefficacyinQi-DeficiencytypeofLungandKidney.ltcanbetterconrrolpatients'symptomsandsigns.ltisworthtopromotean
此文档下载收益归作者所有